Martti Sakari Vaara

This inventor holds 14 USPTO granted patents, plus 1 CIPO patent and 3 EPO patents. Top assignees: Northern Antibiotics, Ltd., Northern Antibiotics Oy, Alko Group Ltd.. Active years: 1985-2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Martti Sakari Vaara. Retrieved from https://idiyas.com/inventor/martti-sakari-vaara

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 14

% Patents Active = 92.9

CIPO Patents = 1

EPO Patents = 3 (Patent Applications = 3)

Average Co-Inventor Count = 2.3

ph-index = 5

Forward Citations = 155(Granted Patents)

Location History:

Helsinki, SF-00320, FI (1985)
00400 Helsinki, FI (1994)
Helsinki, FI (1990 - 2015)
Espoo, FI (2017)

Company Filing History:

6 out of 6

Northern Antibiotics, Ltd.

patents

3 out of 3

Northern Antibiotics Oy

Dorr-Oliver Incorporated

patents

5. 2 out of 834,570

Other

patents

Years Active: 1985-2017

Loading Chart...

14 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9763996 - Polymyxin derivative and uses thereof (2017-09-19),

2. 9096649 - Polymyxin derivatives and uses thereof (2015-08-04),

3. 9090669 - Short fatty acid tail polymyxin derivatives and uses thereof (2015-07-28),

4. 9067974 - Polymyxin derivatives and uses thereof (2015-06-30),

5. 8680234 - Polymyxin derivatives and uses thereof (2014-03-25),

6. 8642535 - Short fatty acid tail polymyxin derivatives and uses thereof (2014-02-04),

7. 8329645 - Polymyxin derivatives and uses thereof (2012-12-11),

8. 8193148 - Short fatty acid tail polymyxin derivatives and uses thereof (2012-06-05),

9. 7807637 - Polymyxin derivatives and uses thereof (2010-10-05),

10. 5569483 - Degraded polysaccharide derivatives (1996-10-29),

11. 5525368 - Degraded polysaccharide derivatives and foodstuffs containing same (1996-06-11),

12. 5366755 - Foodstuffs containing novel degraded cellulose derivatives (1994-11-22),

13. 4914029 - Process for steeping cereals with a new enzyme preparation (1990-04-03),

14. 4510132 - Compounds for use in antibacterial therapy (1985-04-09),

Title: The Innovative Journey of Martti Sakari Vaara

Introduction

Martti Sakari Vaara is a prominent inventor based in Helsinki, Finland, recognized for his significant contributions to the field of pharmaceuticals. With a portfolio of 9 patents, he has dedicated his work to developing innovative solutions, particularly in treating infections caused by Gram-negative bacteria.

Latest Patents

Among his latest inventions, Vaara has developed a series of polymyxin derivatives with enhanced properties. His first patent focuses on a polymyxin derivative and its uses, as detailed in the formula (I). This invention outlines methods for treating infections caused by Gram-negative bacteria, improving pharmacokinetic properties, and reducing nephrotoxicity. Additionally, he investigates combination products comprising various polymyxin derivatives and introduces methods to sensitize bacteria to antibacterial agents and enhance host defense mechanisms.

Career Highlights

Vaara's career has been marked by his association with leading companies in the pharmaceutical sector, notably Northern Antibiotics, Ltd. and Northern Antibiotics Oy. His extensive experience in these organizations has allowed him to refine his expertise in antibiotic development and therapeutic applications.

Collaborations

Throughout his professional journey, Martti Sakari Vaara has collaborated closely with Timo Ilmari Vaara, contributing to various projects aimed at advancing medical technology and treatments. Their partnership has been instrumental in pushing the boundaries of antibiotic research.

Conclusion

Martti Sakari Vaara's innovative spirit and commitment to improving antibiotic efficacy continue to make a profound impact in the medical field. With several groundbreaking patents to his name, he remains a pivotal figure in the ongoing battle against bacterial infections, showcasing the vital role of inventors in advancing healthcare solutions.

Profile summary based on public USPTO records.